Benjamin J. Hindson Ph.D.
Net Worth

Last updated:

What is Benjamin J. Hindson Ph.D. net worth?

The estimated net worth of Dr. Benjamin J. Hindson Ph.D. is at least $83,111,956 as of 22 Nov 2024. He owns shares worth $4,567,672 as insider, has earned $75,469,434 from insider trading and has received compensation worth at least $3,074,850 in 10x Genomics, Inc..

What is the salary of Benjamin J. Hindson Ph.D.?

Dr. Benjamin J. Hindson Ph.D. salary is $614,970 per year as Co-Founder, Pres, Chief Scientific Officer & Director in 10x Genomics, Inc..

How old is Benjamin J. Hindson Ph.D.?

Dr. Benjamin J. Hindson Ph.D. is 50 years old, born in 1975.

What stocks does Benjamin J. Hindson Ph.D. currently own?

As insider, Dr. Benjamin J. Hindson Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
10x Genomics, Inc. (TXG) Co-Founder, Pres, Chief Scientific Officer & Director 339,897 $13.44 $4,567,672

What does 10x Genomics, Inc. do?

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Benjamin J. Hindson Ph.D. insider trading

10x Genomics, Inc.

Dr. Benjamin J. Hindson Ph.D. has made 50 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 5,807 units of TXG stock worth $79,486 on 22 Nov 2024.

The largest trade he's ever made was exercising 113,920 units of TXG stock on 28 Dec 2021. As of 22 Nov 2024 he still owns at least 339,897 units of TXG stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Common Stock 5,807 $13.69 $79,486
Sale
Class A Common Stock 4,351 $22.53 $98,028
Sale
Class A Common Stock 4,087 $24.3 $99,330
Sale
Class A Common Stock 2,613 $46.34 $121,097
Option
Stock Option (right to buy) 8,334 $11.48 $95,674
Option
Class A Common Stock 8,334 $11.48 $95,674
Sale
Class A Common Stock 3,449 $43.34 $149,469
Sale
Class A Common Stock 3,449 $45.78 $157,899
Option
Class A Common Stock 6,970 $11.48 $80,016
Option
Stock Option (right to buy) 6,970 $11.48 $80,016
Sale
Class A Common Stock 1,727 $61.77 $106,679
Sale
Class A Common Stock 5,243 $62.36 $326,933
Option
Class A Common Stock 968 $11.48 $11,113
Option
Class A Common Stock 12,972 $5.04 $65,379
Option
Stock Option (right to buy) 12,972 $5.04 $65,379
Sale
Class A Common Stock 13,940 $60.03 $836,832
Option
Stock Option (right to buy) 968 $11.48 $11,113
Sale
Class A Common Stock 791 $55.06 $43,553
Sale
Class A Common Stock 243 $55.06 $13,379
Sale
Class A Common Stock 619 $55.06 $34,083
Sale
Class A Common Stock 735 $55.06 $40,471
Sale
Class A Common Stock 1,742 $47.75 $83,186
Option
Class A Common Stock 34,266 $5.04 $172,701
Option
Stock Option (right to buy) 34,266 $5.04 $172,701
Sale
Class A Common Stock 915 $34.07 $31,172
Sale
Class A Common Stock 359 $34.07 $12,230
Sale
Class A Common Stock 1,087 $34.07 $37,032
Sale
Class A Common Stock 1,292 $35.19 $45,467
Sale
Class A Common Stock 1,264 $48.76 $61,638
Sale
Class A Common Stock 360 $78.59 $28,294
Option
Stock Option (right to buy) 41,666 $43.03 $1,792,888
Option
Class A Common Stock 41,666 $43.03 $1,792,888
Sale
Class A Common Stock 41,666 $146.88 $6,120,027
Option
Class A Common Stock 113,920 $1.14 $129,299
Option
Stock Option (right to buy) 59,968 $1.2 $71,962
Sale
Class A Common Stock 41,666 $150.16 $6,256,358
Option
Class A Common Stock 41,666 $30.37 $1,265,271
Option
Stock Option (right to buy) 41,666 $30.37 $1,265,271
Sale
Class A Common Stock 351 $148.38 $52,082
Sale
Class A Common Stock 41,666 $162.87 $6,786,016
Option
Class A Common Stock 41,666 $8.26 $344,161
Option
Stock Option (right to buy) 41,666 $8.26 $344,161
Sale
Class A Common Stock 41,666 $143.51 $5,979,321
Option
Stock Option (right to buy) 41,666 $5.04 $209,997
Option
Class A Common Stock 41,666 $5.04 $209,997
Sale
Class A Common Stock 41,666 $177.04 $7,376,340
Option
Class A Common Stock 41,666 $5.04 $209,997
Option
Stock Option (right to buy) 41,666 $5.04 $209,997
Sale
Class A Common Stock 337 $161.85 $54,543
Option
Class A Common Stock 41,666 $3.12 $129,998
Sale
Class A Common Stock 41,666 $181.57 $7,565,379
Option
Stock Option (right to buy) 41,666 $3.12 $129,998
Sale
Class A Common Stock 41,666 N/A N/A
Option
Stock Option (right to buy) 41,666 N/A N/A
Option
Class A Common Stock 41,666 N/A N/A
Sale
Class A Common Stock 41,666 $175.65 $7,318,633
Option
Stock Option (right to buy) 41,666 $1.2 $49,999
Option
Class A Common Stock 41,666 $1.2 $49,999
Sale
Class A Common Stock 351 $162.66 $57,094
Sale
Class A Common Stock 41,666 $192.77 $8,031,871
Option
Class A Common Stock 41,666 $1.14 $47,291
Option
Stock Option (right to buy) 41,666 $1.14 $47,291
Option
Stock Option (right to buy) 41,666 $1.07 $44,583
Option
Class A Common Stock 41,666 $1.07 $44,583
Sale
Class A Common Stock 41,666 $183.41 $7,641,753
Option
Class A Common Stock 41,666 N/A N/A
Option
Stock Option (right to buy) 41,666 $0.98 $40,624
Sale
Class A Common Stock 41,666 $78.77 $3,281,822
Sale
Class A Common Stock 41,666 $157.01 $6,541,937
Sale
Class A Common Stock 33,750 N/A N/A
Sale
Class A Common Stock 33,750 N/A N/A
Option
Class A Common Stock 36,636 N/A N/A
Option
Stock Option (right to buy) 36,636 $1.04 $38,101
Option
Class A Common Stock 36,636 $1.04 $38,101
Option
Stock Option (right to buy) 36,636 N/A N/A
Option
Stock Option (right to buy) 33,750 N/A N/A
Option
Class A Common Stock 33,750 N/A N/A
Sale
Class A Common Stock 33,750 N/A N/A
Option
Class A Common Stock 12,688 N/A N/A
Sale
Class A Common Stock 12,688 N/A N/A
Option
Stock Option (right to buy) 12,688 N/A N/A
Option
Class A Common Stock 21,062 N/A N/A
Sale
Class A Common Stock 21,062 N/A N/A
Sale
Class A Common Stock 2,552 N/A N/A
Option
Stock Option (right to buy) 21,062 N/A N/A
Option
Class A Common Stock 33,750 N/A N/A
Sale
Class A Common Stock 33,750 N/A N/A
Option
Stock Option (right to buy) 33,750 N/A N/A
Option
Stock Option (right to buy) 6,058 N/A N/A
Sale
Class A Common Stock 6,058 N/A N/A
Option
Class A Common Stock 6,058 N/A N/A
Option
Class A Common Stock 27,692 N/A N/A
Sale
Class A Common Stock 27,692 N/A N/A
Option
Stock Option (right to buy) 27,692 N/A N/A
Sale
Class A Common Stock 33,750 N/A N/A
Option
Class A Common Stock 33,750 N/A N/A
Option
Stock Option (right to buy) 33,750 N/A N/A
Sale
Class A Common Stock 33,750 N/A N/A
Option
Stock Option (right to buy) 33,750 N/A N/A
Option
Class A Common Stock 33,750 N/A N/A
Option
Class A Common Stock 33,750 N/A N/A
Sale
Class A Common Stock 33,750 N/A N/A
Option
Stock Option (right to buy) 33,750 N/A N/A
Option
Stock Option (right to buy) 33,750 N/A N/A
Option
Class A Common Stock 33,750 N/A N/A
Sale
Class A Common Stock 33,750 N/A N/A
Option
Class A Common Stock 33,750 N/A N/A
Sale
Class A Common Stock 33,750 N/A N/A
Option
Stock Option (right to buy) 33,750 N/A N/A
Sale
Class A Common Stock 33,750 N/A N/A
Option
Class A Common Stock 33,750 N/A N/A
Option
Stock Option (right to buy) 33,750 N/A N/A
Option
Class A Common Stock 67,500 N/A N/A
Option
Stock Option (right to buy) 67,500 N/A N/A

10x Genomics key executives

10x Genomics, Inc. executives and other stock owners filed with the SEC: